Comparative study of the efficacy of UBE-PLIF and MIS-TLIF in the treatment of lumbar degenerative diseases
Objective To explore the effects of unilateral biportal endoscopic-posterior lumbar interbody fusion(UBE-PLIF)and minimally invasive-transforaminal lumbar interbody fusion(MIS-TLIF)in the treatment of lumbar degenerative disea-ses,aiming to provide a reference for clinical treatment.Methods A total of 127 patients with lumbar degenerative diseases admitted to Pingliang Second People's Hospital from August 2020 to December 2023 were selected as the study participants,who were randomly assigned to a control group(n=63)and an observation group(n=64)using a random number table method.Patients in the control group received MIS-TLIF treatment,while those in the observation group UBE-PLIF treat-ment.The bone fusion status of the two groups was evaluated at 6 months postoperatively;the time of operation,intraoper-ative blood loss,postoperative drainage volume,and length of hospital stay were compared between the two groups.The pain numerical rating scale(NRS)scores and Oswestry disability index(ODI)before and after surgery(3 months,6 months)were compared between the two groups;and the occurrence of complications within 6 months postoperatively was compared between the two groups.Results No significant difference was observed in the fusion rate between the two groups(P>0.05).The time of operation in the observation group was significantly longer than in the control group,while the intraoperative blood loss and postoperative drainage volume were both significantly less than in the control group(P<0.05).Before surgery and at 6 months postoperatively,no significant differences were noted in the lumbar NRS score,leg NRS score,and ODI between the two groups(P>0.05);at 3 months postoperatively,the lumbar NRS score,leg NRS score,and ODI in the observation group were significantly lower than those in the control group(P<0.05).No significant difference was found in the occurrence of complications between the two groups(P>0.05).Conclusion The clinical effica-cy of UBE-PLIF is comparable to that of MIS-TLIF in treating lumbar degenerative diseases,but UBE-PLIF has the advan-tages of less intraoperative blood loss and postoperative drainage volume,lighter postoperative lumbar and leg pain,and fas-ter recovery,which is worth promoting in clinical practice.
万方数据
维普
